Standard BioTools News

Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript

Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 11 12:45 ET

Standard BioTools | 10-Q: Quarterly report

Futu NewsMay 9 16:59 ET · Announcements

Standard BioTools Reaffirms Guidance

Outlook for 2024For fiscal year 2024, the Company reaffirmed full year revenue guidance, which is expected to be in the range of $200 million to $205 million.

BenzingaMay 8 17:39 ET

Standard BioTools: Strategic Insights and Regulatory Updates

TipRanksMay 8 16:43 ET

Standard BioTools Q1 2024 GAAP EPS $(0.27) Misses $(0.12) Estimate, Sales $45.540M Miss $46.006M Estimate

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.12) by 125 percent. This is a 28.57 percent decrease over losses of $(0

BenzingaMay 8 16:26 ET

Express News | Standard BioTools Inc FY2024 Rev View $201.0 Mln -- Lseg Ibes Data

ReutersMay 8 16:21 ET

Express News | Standard BioTools Inc: Qtrly Shr Loss $0.27

ReutersMay 8 16:21 ET

Express News | Standard BioTools Inc: For Fiscal Year 2024, Co Reaffirmed Full Year Revenue Guidance

ReutersMay 8 16:20 ET

Express News | Standard BioTools Inc: On Track to Cash Flow Positive in Full-Year 2026

ReutersMay 8 16:20 ET

Standard BioTools Backs 2024 Rev $200M-$205M >LAB

Standard BioTools Backs 2024 Rev $200M-$205M >LAB

Dow JonesMay 8 16:09 ET

Standard BioTools 1Q Rev $45.5M >LAB

Standard BioTools 1Q Rev $45.5M >LAB

Dow JonesMay 8 16:08 ET

Standard BioTools 1Q Loss/Shr 27c >LAB

Standard BioTools 1Q Loss/Shr 27c >LAB

Dow JonesMay 8 16:08 ET

Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, Vs. Street Est of $46M

04:07 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M

MT NewswiresMay 8 16:07 ET

Express News | Standard BioTools Q1 Adjusted Gross Margin 49.2%

ReutersMay 8 16:01 ET

Express News | Standard BioTools Reports First Quarter 2024 Financial Results

ReutersMay 8 16:01 ET

Express News | Standard BioTools Q1 Gross Margin 53.1%

ReutersMay 8 16:01 ET

Express News | Standard BioTools Q1 Net Income USD -32.157 Million

ReutersMay 8 16:01 ET

Express News | Standard BioTools Q1 Pretax Profit USD -32.029 Million

ReutersMay 8 16:01 ET

Express News | Standard BioTools Q1 Operating Income USD -60.182 Million

ReutersMay 8 16:01 ET

Press Release: Standard BioTools Reports First Quarter 2024 Financial Results

Standard BioTools Reports First Quarter 2024 Financial Results -- Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaini

Dow JonesMay 8 16:01 ET